| Hebrew University of Jerusalem, B.A.s | |
| Economics and Political Science |
Ruben Krupik is CEO of Clal Biotech, as well as being responsible for defining the vision, strategy and direction of the Company. Ruben serves as active chairman in D-pharm, CureTech, Mediwound and Andromeda.
